27 min listen
Circulating Tumor DNA in Lymphoma Monitoring With Drs. Annette Kim and Davide Rossi
FromThe Hematologist
Circulating Tumor DNA in Lymphoma Monitoring With Drs. Annette Kim and Davide Rossi
FromThe Hematologist
ratings:
Length:
19 minutes
Released:
Sep 18, 2018
Format:
Podcast episode
Description
In this podcast, Contributing Editor Dr. Annette Kim has a conversation with Dr. Davide Rossi. They discuss Dr. Kim's Diffusion article from the September/October 2018 issue of The Hematologist. The article titled, "Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?," covers a study that showcases the utility of circulating tumor DNA monitoring in classic Hodgkin lymphoma. You can find her Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8943.aspx.
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Sep 18, 2018
Format:
Podcast episode
Titles in the series (100)
BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia: In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or sm by The Hematologist